Reva expands bioresorbable stent footprint in Europe by Conor Hale Tuesday, January 8, 2019 Reva Medical expanded its operations to seven European countries, while it looks to build up clinical evidence for its bioresorbable stents.
Reva secures CE mark for bioresorbable scaffold in lower-leg PAD by Conor Hale Monday, July 30, 2018 Reva netted a CE mark for the first drug-eluting bioresorbable scaffold in lower-leg peripheral artery disease, and the company’s first in the space.
Reva gets CE mark for bioresorbable scaffold with thin struts by Nick Paul Taylor Monday, February 26, 2018 The European regulatory nod clears Reva to push a device it thinks addresses some shortcomings of other products in the sector.
Reva gets CE mark for drug-eluting bioresorbable scaffold by Nick Paul Taylor Wednesday, April 5, 2017 Reva Medical has secured a CE mark for its drug-eluting bioresorbable coronary scaffold, Fantom.
